Worm, Margitta
Hanschmann-Mohn, Theresa
Scherer Hofmeier, Kathrin
Cardona, Victòria
Turner, Paul
Dölle-Bierke, Sabine
Article History
Received: 18 July 2019
Accepted: 5 September 2019
First Online: 17 October 2019
Conflict of interest
: P. Turner reports grants from UK Medical Research Council, during the conduct of the study; grants from National Institute for Health Research Policy Research Programme, outside the submitted work; and received consultancy and lecture fees from Aimmune Therapeutics, Allergenis DBV Technologies; research support by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. V. Cardona reports personal fees from ALK, outside the submitted work. M. Worm received grants for consulting and honorarium for speaker activity by ALK-Abelló Arzneimittel GmbH, Mylan Germany GmbH, Bencard Allergie GmbH Novartis AG, Biotest AG, Actelion Pharmaceuticals Deutschland GmbH, Sanofi-Aventis Deutschland GmbH, HAL Allergie GmbH. T. Hanschmann-Mohn, K. Scherer Hofmeier, and S. Dölle-Bierke declare that they have no competing interests.